Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
56,822,940
-
Shares change
-
-3,121,579
-
Total reported value, excl. options
-
$139,215,632
-
Value change
-
-$10,696,319
-
Put/Call ratio
-
80%
-
Number of buys
-
56
-
Number of sells
-
-75
-
Price
-
$2.45
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q2 2023
153 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q2 2023.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56,822,940 shares
.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (7,167,591 shares), Avidity Partners Management LP (6,080,000 shares), ORBIMED ADVISORS LLC (5,463,000 shares), BlackRock Inc. (5,089,147 shares), Prosight Management, LP (4,651,920 shares), MILLENNIUM MANAGEMENT LLC (3,741,109 shares), VANGUARD GROUP INC (3,033,070 shares), SPHERA FUNDS MANAGEMENT LTD. (1,988,228 shares), Granahan Investment Management, LLC (1,899,019 shares), and FRANKLIN RESOURCES INC (1,388,157 shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.